Novartis CEO says Covid-related doctor visit delays likely impacting cancer diagnosis rates

Novartis CEO Vasant Narasimhan told CNBC there are now lower rates of diagnoses due to reduced hospital visits during the coronavirus pandemic.

from Health and Science https://ift.tt/3x6tqQN
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH